AQR Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306M | Buy |
|
|||||
|
2025
Q1 | $204M | Buy |
|
|||||
|
2024
Q4 | $84.4M | Buy |
|
|||||
|
2024
Q3 | $42.1M | Buy |
|
|||||
|
2024
Q2 | $4.56M | Buy |
|
|||||
|
2024
Q1 | $1.98M | Sell |
|
|||||
|
2023
Q4 | $5.5M | Sell |
|
|||||
|
2023
Q3 | $7.88M | Sell |
|
|||||
|
2023
Q2 | $15.2M | Buy |
|
|||||
|
2023
Q1 | $7.3M | Buy |
|
|||||
|
2022
Q4 | $5.1M | Buy |
|
|||||
|
2022
Q3 | $2.47M | Buy |
|
|||||
|
2022
Q2 | $663K | Buy |
|
|||||
|
2022
Q1 | $471K | Buy |
|
|||||
|
2021
Q4 | $203K | Sell |
|
|||||
|
2021
Q3 | $259K | Sell |
|
|||||
|
2021
Q2 | $860K | Buy |
|
|||||
|
2021
Q1 | $555K | Sell |
|
|||||
|
2020
Q4 | $2.63M | Sell |
|
|||||
|
2020
Q3 | $8.18M | Buy |
|
|||||
|
2020
Q2 | $1.73M | Buy |
|
|||||
|
2020
Q1 | $595K | Sell |
|
|||||
|
2019
Q4 | $1.26M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.18M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $874K | Sell |
|
|||||
|
2015
Q4 | $19.4M | Sell |
|
|||||
|
2015
Q3 | $23M | Sell |
|
|||||
|
2015
Q2 | $42.5M | Buy |
|
|||||
|
2015
Q1 | $4.55M | Buy |
|
|||||
|
2014
Q4 | $370K | Sell |
|
|||||
|
2014
Q3 | $2.93M | Sell |
|
|||||
|
2014
Q2 | $6.09M | Buy |
|
|||||
|
2014
Q1 | $1.68M | Sell |
|
|||||
|
2013
Q4 | $5.63M | Buy |
|
|||||
|
2013
Q3 | $1.26M | Buy |
|
|||||
|
2013
Q2 | $826K | Buy |
|